Literature DB >> 16757586

Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

George A Jacoby1, Kelley E Walsh, Victoria J Walker.   

Abstract

Antibiotic disks with and without clavulanic acid, 3-aminophenylboronic acid, or EDTA were tested with a set of 55 Klebsiella pneumoniae and Escherichia coli strains producing well-characterized extended-spectrum, AmpC, or carbapenem-hydrolyzing beta-lactamases. A relatively simple scheme was devised for distinguishing beta-lactamase types in clinical isolates with or without intact outer membrane porins.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16757586      PMCID： PMC1489443          DOI： 10.1128/JCM.00062-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  45 in total

1.  Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia.

Authors:  S Ben Redjeb; G Fournier; C Mabilat; A Ben Hassen; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1990-01-15       Impact factor: 2.742

2.  Broad-spectrum, transmissible beta-lactamases.

Authors:  G A Jacoby; A A Medeiros; T F O'Brien; M E Pinto; H Jiang
Journal:  N Engl J Med       Date:  1988-09-15       Impact factor: 91.245

3.  Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.

Authors:  A Petit; D L Sirot; C M Chanal; J L Sirot; R Labia; G Gerbaud; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants.

Authors:  M Gonzalez Leiza; J C Perez-Diaz; J Ayala; J M Casellas; J Martinez-Beltran; K Bush; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 5.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids.

Authors:  C M Chanal; D L Sirot; A Petit; R Labia; A Morand; J L Sirot; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors:  A Vuye; G Verschraegen; G Claeys
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

8.  Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam.

Authors:  A Buré; P Legrand; G Arlet; V Jarlier; G Paul; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

9.  Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  M H Nicolas; V Jarlier; N Honore; A Philippon; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

10.  TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

Authors:  G C Paul; G Gerbaud; A Bure; A M Philippon; B Pangon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191
View more
  13 in total

1.  Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers.

Authors:  Mark A Fisher; Paul D Stamper; Kristine M Hujer; Zachary Love; Ann Croft; Samuel Cohen; Robert A Bonomo; Karen C Carroll; Cathy A Petti
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

Review 2.  A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Authors:  Pranita D Tamma; Yohei Doi; Robert A Bonomo; J Kristie Johnson; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

3.  Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.

Authors:  Hanna E Sidjabat; David L Paterson; Zubair A Qureshi; Jennifer M Adams-Haduch; Alexandra O'Keefe; Alvaro Pascual; Jesús Rodríguez-Baño; Yohei Doi
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

4.  Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound.

Authors:  Yohei Doi; Brian A Potoski; Jennifer M Adams-Haduch; Hanna E Sidjabat; Anthony W Pasculle; David L Paterson
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

5.  Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.

Authors:  Xuan Qin; Danielle M Zerr; Scott J Weissman; Janet A Englund; Donna M Denno; Eileen J Klein; Phillip I Tarr; Justin Kwong; Jennifer R Stapp; Luis G Tulloch; Emmanouil Galanakis
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

Review 6.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.

Authors:  Fred C Tenover; Shannon L Emery; Carol A Spiegel; Patricia A Bradford; Samantha Eells; Andrea Endimiani; Robert A Bonomo; John E McGowan
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

Review 8.  Pseudomonas aeruginosa resistance phenotypes and phenotypic highlighting methods.

Authors:  Maria Bălăşoiu; A T Bălăşoiu; Rodica Mănescu; Carmen Avramescu; Oana Ionete
Journal:  Curr Health Sci J       Date:  2014-03-29

9.  Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico.

Authors:  Mussaret B Zaidi; Teresa Estrada-García; Freddy D Campos; Rodolfo Chim; Francisco Arjona; Magda Leon; Alba Michell; Damien Chaussabel
Journal:  Front Microbiol       Date:  2013-10-01       Impact factor: 5.640

10.  Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana.

Authors:  Daniel Oduro-Mensah; Noah Obeng-Nkrumah; Evelyn Yayra Bonney; Ebenezer Oduro-Mensah; Kingsley Twum-Danso; Yaa Difie Osei; Sammy Tawiah Sackey
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-04       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.